BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20884845)

  • 1. Familial aggregation of left ventricular geometry and association with parental heart failure: the Framingham Heart Study.
    Lam CS; Liu X; Yang Q; Larson MG; Pencina MJ; Aragam J; Redfield MM; Benjamin EJ; Vasan RS
    Circ Cardiovasc Genet; 2010 Dec; 3(6):492-8. PubMed ID: 20884845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern.
    Lieb W; Gona P; Larson MG; Aragam J; Zile MR; Cheng S; Benjamin EJ; Vasan RS
    JACC Cardiovasc Imaging; 2014 Sep; 7(9):870-8. PubMed ID: 25129518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations of biomarkers representing distinct biological pathways to left ventricular geometry.
    Velagaleti RS; Gona P; Levy D; Aragam J; Larson MG; Tofler GH; Lieb W; Wang TJ; Benjamin EJ; Vasan RS
    Circulation; 2008 Nov; 118(22):2252-8, 5p following 2258. PubMed ID: 19001021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up.
    Desai RV; Ahmed MI; Mujib M; Aban IB; Zile MR; Ahmed A
    Am J Cardiol; 2011 Jan; 107(2):321-4. PubMed ID: 21129719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.
    Velagaleti RS; Gona P; Pencina MJ; Aragam J; Wang TJ; Levy D; D'Agostino RB; Lee DS; Kannel WB; Benjamin EJ; Vasan RS
    Am J Cardiol; 2014 Jan; 113(1):117-22. PubMed ID: 24210333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure.
    Woodiwiss AJ; Libhaber CD; Majane OH; Libhaber E; Maseko M; Norton GR
    Am J Hypertens; 2008 Oct; 21(10):1144-51. PubMed ID: 18756261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.
    Katz DH; Beussink L; Sauer AJ; Freed BH; Burke MA; Shah SJ
    Am J Cardiol; 2013 Oct; 112(8):1158-64. PubMed ID: 23810323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement.
    Duncan AI; Lowe BS; Garcia MJ; Xu M; Gillinov AM; Mihaljevic T; Koch CG
    Ann Thorac Surg; 2008 Jun; 85(6):2030-9. PubMed ID: 18498815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy, abnormal ventricular geometry and relative wall thickness are associated with increased risk of stroke in hypertensive patients among the Han Chinese.
    Wang S; Xue H; Zou Y; Sun K; Fu C; Wang H; Hui R
    Hypertens Res; 2014 Sep; 37(9):870-4. PubMed ID: 24830536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study.
    Myasoedova E; Davis JM; Crowson CS; Roger VL; Karon BL; Borgeson DD; Therneau TM; Matteson EL; Rodeheffer RJ; Gabriel SE
    Arthritis Rheum; 2013 Jul; 65(7):1713-8. PubMed ID: 23553738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Santucci A; Santucci C; Reboldi G; Porcellati C
    Am J Cardiol; 1996 Jul; 78(2):197-202. PubMed ID: 8712142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study).
    Toprak A; Wang H; Chen W; Paul T; Srinivasan S; Berenson G
    Am J Cardiol; 2008 Jun; 101(11):1621-5. PubMed ID: 18489940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between basal septal hypertrophy and left ventricular geometry in a community population.
    Gao L; Ma W; Li M; Yang Y; Qi L; Zhang B; Wang C; Zhang Y; Huo Y
    BMC Cardiovasc Disord; 2022 Dec; 22(1):579. PubMed ID: 36587201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.
    Wachtell K; Bella JN; Liebson PR; Gerdts E; Dahlöf B; Aalto T; Roman MJ; Papademetriou V; Ibsen H; Rokkedal J; Devereux RB
    Hypertension; 2000 Jan; 35(1 Pt 1):6-12. PubMed ID: 10642267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
    Taniguchi I; Kawai M; Date T; Yoshida S; Seki S; Taniguchi M; Shimizu M; Mochizuki S
    Circ J; 2006 Aug; 70(8):995-1000. PubMed ID: 16864931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular concentric geometry predicts incident diabetes mellitus independent of established risk factors in the general population: the Copenhagen City Heart Study.
    Modin D; Møgelvang R; Jørgensen PG; Jensen MT; Seferovic JP; Biering-Sørensen T
    Cardiovasc Diabetol; 2019 Mar; 18(1):37. PubMed ID: 30894177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study.
    Tsao CW; Gona PN; Salton CJ; Chuang ML; Levy D; Manning WJ; O'Donnell CJ
    J Am Heart Assoc; 2015 Sep; 4(9):e002188. PubMed ID: 26374295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.